Authors:
ROSELL R
SACRISTAN JA
DUTHIE T
CARDENAL F
ARTAL A
CARRATO A
LOMAS M
BARNETO I
BAMETO I
MASSUTI B
Citation: R. Rosell et al., COST-EFFECTIVENESS OF GEMCITABINE (GEMZAR(TM)) PLUS CISPLATIN VERSUS ETOPOSIDE PLUS CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) IN SPAIN, Annals of oncology, 9, 1998, pp. 445-445